185 related articles for article (PubMed ID: 36479564)
1. Effect of Danhong injection on prognosis and inflammatory factor expression in patients with acute coronary syndrome during the perioperative period of percutaneous coronary intervention: A systematic review and meta-analysis.
Li Y; Li D; Wang W; Li X; Li P; Zhang Y; Lin Q; Li Y
Front Cardiovasc Med; 2022; 9():1029387. PubMed ID: 36479564
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Efficacy of Danhong Injections at Different Time-points During the Perioperative Period of Acute Myocardial Infarction: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
He QY; Yu XY; Xiao Z; Sun X; Zhu WF; Yi XQ; Chen Q; Zhang JH; Chen SX; Zhou X; Nie HY; Shang HC; Chen XF
Front Pharmacol; 2021; 12():643446. PubMed ID: 33995051
[No Abstract] [Full Text] [Related]
3. The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.
Zou JB; Zhang XF; Wang J; Wang F; Cheng JX; Yang FY; Song X; Wang Y; Liang YL; Shi YJ
Front Pharmacol; 2018; 9():550. PubMed ID: 29915535
[No Abstract] [Full Text] [Related]
4. [Effect of danhong injection on ET-1, sP-sel, and hs-CRP in patients with acute coronary syndrome undergoing percutaneous coronary intervention].
Zhao PX; Jiang S
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jan; 31(1):11-4. PubMed ID: 21434335
[TBL] [Abstract][Full Text] [Related]
5. Effects of sodium tanshinone IIA sulfonate injection on inflammatory factors and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials.
Kan Z; Yan W; Yang M; Gao H; Meng D; Wang N; Fang Y; Wu L; Song Y
Front Pharmacol; 2023; 14():1144419. PubMed ID: 36959861
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of Danhong injection for treating myocardial infarction: a systematic review and meta-analysis of randomized controlled trials.
Yang S; Wang Y; Shen H; Chen T; Du H
Front Pharmacol; 2024; 15():1371959. PubMed ID: 38939841
[TBL] [Abstract][Full Text] [Related]
7. [Effect of danhong injection on platelet activation and inflammatory factors in patients of acute coronary syndrome after intervention therapy].
Chen ZQ; Hong L; Wang H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Aug; 29(8):692-4. PubMed ID: 19848198
[TBL] [Abstract][Full Text] [Related]
8. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.
Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
PLoS One; 2017; 12(2):e0171682. PubMed ID: 28231287
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
Wei J; Liu S; Wang X; Li B; Qiao L; Wang Y; Zhu M
Evid Based Complement Alternat Med; 2021; 2021():2672516. PubMed ID: 34931125
[TBL] [Abstract][Full Text] [Related]
10. [Network Meta-analysis of efficacy and safety of different traditional Chinese medicine injections in treating post-acute myocardial infarction heart failure].
Sun Y; Qiao LJ; Wei JJ; Li B; Gao Y; Zhu MJ
Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(21):5932-5945. PubMed ID: 38114189
[TBL] [Abstract][Full Text] [Related]
11. [Meta-analysis of effect of Qishen Yiqi Dripping Pills combined with Western medicine on adverse cardiovascular events and quality of life after percutaneous coronary intervention].
Dai QQ; Shi ZF; Hu JY; Han SJ; Zhong CM; Guan MK; Tian GH; Shang HC
Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(6):1498-1510. PubMed ID: 33787149
[TBL] [Abstract][Full Text] [Related]
12. Effect of Danhong Injection Combined with Naoxintong Tablets on Prognosis and Inflammatory Factor Expression in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.
Lv Y; Pan Y; Gao Y; Lu J; Li Y; Bai J; Zhai J
Acta Cardiol Sin; 2015 Jul; 31(4):301-7. PubMed ID: 27122886
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of short-term high-dose atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials.
Liu Y; Su Q; Li L
Clin Cardiol; 2013 Dec; 36(12):E41-8. PubMed ID: 24038054
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Danhong injection on endothelial function and inflammatory factors after the percutaneous coronary intervention for coronary heart disease: A protocol of systematic review and meta-analysis of randomized controlled trials.
Li S; Duan S; Ning Y; Zhang H; Zheng Q
Medicine (Baltimore); 2020 Jul; 99(27):e20783. PubMed ID: 32629660
[TBL] [Abstract][Full Text] [Related]
15. Danhong Injection (a Traditional Chinese Patent Medicine) for Acute Myocardial Infarction: A Systematic Review and Meta-Analysis.
Liao P; Wang L; Guo L; Zeng R; Huang J; Zhang M
Evid Based Complement Alternat Med; 2015; 2015():646530. PubMed ID: 26451156
[TBL] [Abstract][Full Text] [Related]
16. Danhong injection in the treatment of acute coronary syndrome: a systematic review and meta-analysis.
Wu JR; Zhang XM; Zhang B
Am J Chin Med; 2015; 43(2):199-214. PubMed ID: 25787298
[TBL] [Abstract][Full Text] [Related]
17. Thrombomodulin can predict the incidence of second events in patients with acute coronary syndrome: Single-center, retrospective cohort study.
Kosaki R; Minoura Y; Ogura K; Oishi Y; Tanaka L; Arai K; Nomura K; Sakai K; Sekimoto T; Nisikura T; Tsujita H; Kondo S; Tsukamoto S; Hamazaki Y; Kobayashi Y
J Cardiol; 2018 Dec; 72(6):494-500. PubMed ID: 29887328
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive Effect and Safety of Chinese Herbal Medicine in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Zheng S; Ma X; Kong Z; Yang C
Altern Ther Health Med; 2023 Nov; ():. PubMed ID: 37917887
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of NT-proBNP in Patients With Successful PCI for ACS and Normal Left Ventricular Ejection Fraction.
Wang JL; Guo CY; Li HW; Zhao XQ; Zhao SM
Am J Med Sci; 2022 Apr; 363(4):333-341. PubMed ID: 34986361
[TBL] [Abstract][Full Text] [Related]
20. The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Shi Z; Zhao C; Hu J; Dai Q; Guan M; Zhong C; Tian G; Shang H
Evid Based Complement Alternat Med; 2020; 2020():3834128. PubMed ID: 32508947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
